The following video is from Tuesday's edition of Market Foolery, in which host Chris Hill and Motley Fool analysts Matt Argersinger and Jason Moser take a deep dive into today's best investing news.

Shares of Johnson & Johnson (NYSE:JNJ) got a small boost after the company beat expectations on Q3 profits, in part because of a strong performance from the company's drug division. In this segment, Matt and Jason look at this Dow mega blue chip, and tell investors whether the company is a buy today.

Chris Hill owns shares of Johnson & Johnson. Jason Moser and Matthew Argersinger have no position in any stocks mentioned. The Motley Fool recommends and owns shares of Johnson & Johnson and National Oilwell Varco. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.